Welcome to our dedicated page for Neogen SEC filings (Ticker: NEOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Neogen Corporation SEC filings document material events for an operating company focused on food safety and animal safety products. Recent 8-K filings cover quarterly results and financial condition, Regulation FD disclosures related to Petrifilm manufacturing validation, and exhibits containing earnings releases and business updates.
The company’s filings also record governance and leadership matters, including executive appointments and departures, compensatory arrangements, board committee assignments, annual meeting voting results, executive compensation votes, and auditor ratification. These disclosures provide formal records of Neogen’s public-company reporting, operating updates, governance structure and shareholder matters.
Neogen Corp (NEOG) reported an insider equity transaction. A director acquired 19,769 shares of common stock at $6.07 on 10/23/2025 (Transaction Code A). Following this, the director beneficially owned 34,621 common shares directly.
The filing also reports a grant of options to purchase 50,814 shares at an exercise price of $6.07, expiring on 10/23/2035. After the transactions, the director held 50,814 options. The options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.
Neogen Corp (NEOG) — Form 4 insider report: A director reported an award on 10/23/2025. The filing shows 19,769 shares of common stock acquired (Code A) at $6.07, bringing direct beneficial ownership to 48,469 shares. The director was also granted options to purchase 50,814 shares at an exercise price of $6.07, expiring 10/23/2035. A footnote states the options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.
Neogen Corp (NEOG) — Form 4 insider activity: A director reported awards dated 10/23/2025. The filing shows an acquisition of 19,769 shares of common stock and a grant of options covering 50,814 shares with a $6.07 exercise price, expiring on 10/23/2035. The form lists 19,769 common shares and 50,814 derivative securities beneficially owned following the transactions, all held directly. Both the options and RSUs vest in equal annual installments on each of the first three anniversaries of the grants.
Neogen (NEOG) reported an insider equity grant by a director on 10/23/2025. The filing shows 50,814 stock options with a $6.07 exercise price expiring on 10/23/2035, and 19,769 shares acquired.
Per the footnote, the options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants. Following these transactions, the director beneficially owned 112,314 shares, held directly.
Neogen Corporation filed an 8-K/A to correct its Annual Meeting results, confirming that Proposal 2 (say‑on‑pay) was approved on October 23, 2025. Shareholder participation was strong, with 195,086,461 of 217,298,626 shares outstanding and entitled to vote present and voted.
Proposal 2 received 167,126,873 For, 17,679,601 Against, 412,667 Abstain, and 9,805,786 broker non‑votes. Shareholders also ratified the appointment of BDO USA, P.C. as auditor with 181,630,320 For, 13,148,285 Against, and 307,856 Abstain. Director nominees Thierry L. Bernard, Mikhael Nassif, Avi Pelossof, and Andrea F. Wainer each received a majority of votes For.
Neogen Corporation reported results from its 2025 Annual Meeting held on October 23, 2025. A total of 195,086,461 of 217,298,626 shares outstanding and entitled to vote were represented.
Shareholders elected four directors: Thierry L. Bernard (For 168,950,135; Withheld 16,330,540), Mikhael Nassif (For 171,847,536; Withheld 13,433,139), Avi Pelossof (For 171,839,634; Withheld 13,441,041), and Andrea F. Wainer (For 169,573,203; Withheld 15,707,472).
The non-binding advisory vote on executive compensation did not pass (For 167,126,873; Against 17,679,601; Abstain 412,667; Broker Non-Vote 9,805,786). Shareholders ratified BDO USA, P.C. as independent auditor for the fiscal year ending May 31, 2026 (For 181,630,320; Against 13,148,285; Abstain 307,856).
Neogen Corp (NEOG) reported an insider equity event. On 10/13/2025, the Chief Legal Officer had 294 RSUs vest and settle into an equal number of common shares (Code M) at a stated price of $6.04 per share. To satisfy tax obligations, 115 shares were withheld/disposed (Code F) at $6.04. Following these transactions, the officer directly owns 49,851 shares.
Neogen Corp (NEOG) reported an insider equity event by a company officer (Former COO). On 10/13/2025, 783 restricted stock units vested and were settled for an equal number of common shares (transaction code M). To satisfy tax withholding, 383 shares were withheld/disposed (code F) at a price listed as $6.04 per share. Following these transactions, the reporting person directly owned 88,858 common shares.
Neogen Corp (NEOG) insider filing reports routine equity compensation activity. An officer (Former CEO) converted 3,063 restricted stock units into common stock on 10/13/2025 (Code M) at $6.04 per share, and recorded a disposition of 865 shares (Code F) at $6.04 per share the same day. After these transactions, the reporting person beneficially owned 332,849 shares, held directly.
The remarks state each RSU is the economic equivalent of one share, and these RSUs vested and were settled for an equal number of common shares on October 13, 2025.
NEOGEN CORP (NEOG) reporting person Amy M. Rocklin had 9,036 restricted stock units vest on 10/07/2025, which were settled for an equal number of shares at a recorded per-share amount of $5.63. The filing also shows a disposition of 3,534 shares on 10/07/2025 at $5.63, leaving the reporting person with 49,672 shares beneficially owned following the transactions. The transactions were signed by an attorney-in-fact on 10/09/2025.